Top segments and regional performance

Last year, the company generated ‪348.97 M‬ USD, the most of which — ‪348.97 M‬ USD — came from its top-performing segment, Innovative Therapeutic Products and Devices, compared to ‪285.50 M‬ USD the previous year. The greatest contribution came from United States, which accounted for ‪348.97 M‬ USD last year, with ‪285.50 M‬ USD the year before.